Sandro L Pereira
Overview
Explore the profile of Sandro L Pereira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
702
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Andujar B, Pereira S, Busi S, Usnich T, Borsche M, Ertan S, et al.
Environ Int
. 2024 Nov;
194:109151.
PMID: 39571299
Pathogenic variants in the Leucine-rich repeat kinase 2 (LRRK2) gene are a primary monogenic cause of Parkinson's disease (PD). However, the likelihood of developing PD with inherited LRRK2 pathogenic variants...
2.
Scafidi A, Lind-Holm Mogensen F, Campus E, Pailas A, Neumann K, Legrave N, et al.
Heliyon
. 2024 Sep;
10(18):e37792.
PMID: 39315158
Background: Epidemiological studies suggest that metformin reduces the risk of developing several types of cancer, including gliomas, and improves the overall survival in cancer patients. Nevertheless, while the effect of...
3.
Lind-Holm Mogensen F, Sousa C, Ameli C, Badanjak K, Pereira S, Muller A, et al.
J Neuroinflammation
. 2024 Jul;
21(1):174.
PMID: 39014482
Background: Specific microglia responses are thought to contribute to the development and progression of neurodegenerative diseases, including Parkinson's disease (PD). However, the phenotypic acquisition of microglial cells and their role...
4.
Mulica P, Venegas C, Landoulsi Z, Badanjak K, Delcambre S, Tziortziou M, et al.
Biol Proced Online
. 2023 Sep;
25(1):26.
PMID: 37730545
Background: Astrocytes have recently gained attention as key contributors to the pathogenesis of neurodegenerative disorders including Parkinson's disease. To investigate human astrocytes in vitro, numerous differentiation protocols have been developed....
5.
Pereira S, Grossmann D, Delcambre S, Hermann A, Grunewald A
Curr Opin Neurobiol
. 2023 Apr;
80:102720.
PMID: 37023495
Mutations in PRKN cause the second most common genetic form of Parkinson's disease (PD)-a debilitating movement disorder that is on the rise due to population aging in the industrial world....
6.
Wasner K, Smajic S, Ghelfi J, Delcambre S, Prada-Medina C, Knappe E, et al.
Mov Disord
. 2022 Apr;
37(7):1405-1415.
PMID: 35460111
Background: Mutations in the E3 ubiquitin ligase parkin cause autosomal recessive Parkinson's disease (PD). Together with PTEN-induced kinase 1 (PINK1), parkin regulates the clearance of dysfunctional mitochondria. New mitochondria are...
7.
Smajic S, Prada-Medina C, Landoulsi Z, Ghelfi J, Delcambre S, Dietrich C, et al.
Brain
. 2021 Dec;
145(3):964-978.
PMID: 34919646
Idiopathic Parkinson's disease is characterized by a progressive loss of dopaminergic neurons, but the exact disease aetiology remains largely unknown. To date, Parkinson's disease research has mainly focused on nigral...
8.
Badanjak K, Mulica P, Smajic S, Delcambre S, Tranchevent L, Diederich N, et al.
Front Cell Dev Biol
. 2021 Nov;
9:740758.
PMID: 34805149
Parkinson's disease (PD) is a neurodegenerative disease with unknown cause in the majority of patients, who are therefore considered "idiopathic" (IPD). PD predominantly affects dopaminergic neurons in the substantia nigra...
9.
Luth T, Wasner K, Klein C, Schaake S, Tse R, Pereira S, et al.
Front Aging Neurosci
. 2021 Oct;
13:713084.
PMID: 34650424
To establish a workflow for mitochondrial DNA (mtDNA) CpG methylation using Nanopore whole-genome sequencing and perform first pilot experiments on affected biallelic mutation carriers (Parkin-PD) and healthy controls. Mitochondria, including...
10.
Mulica P, Grunewald A, Pereira S
Front Endocrinol (Lausanne)
. 2021 May;
12:668517.
PMID: 34025580
Converging evidence made clear that declining brain energetics contribute to aging and are implicated in the initiation and progression of neurodegenerative disorders such as Alzheimer's and Parkinson's disease. Indeed, both...